Wexford Capital’s C4 Therapeutics CCCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-7,731	Closed	-$12.4K	–	257
2025 Q1	$12.4K	Sell	7,731 -110,600	-93%	-$177K	﹤0.01%	216
2024 Q4	$426K	Buy	118,331 +63,100	+114%	+$227K	0.07%	111
2024 Q3	$315K	Buy	+55,231	New	+$315K	0.08%	118